🔗 Share this article

Texas Attorney General Paxton is suing the makers of acetaminophen, claiming the firms withheld safety concerns that the pain reliever presented to children's neurological development.

The lawsuit follows four weeks after Former President Trump advocated an unverified association between using Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is filing suit against J&J, which formerly manufactured the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by making money from discomfort and marketing drugs without regard for the potential hazards."

Kenvue states there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking millions to line their pockets," the attorney general, a Republican, stated.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the health of US mothers and children."

On its online platform, the company also said it had "consistently assessed the applicable studies and there is no credible data that shows a proven link between taking acetaminophen and autism spectrum disorder."

Groups representing medical professionals and healthcare providers concur.

ACOG has said paracetamol - the main ingredient in acetaminophen - is one of the few options for expectant mothers to treat discomfort and fever, which can pose major wellness concerns if left untreated.

"In over twenty years of studies on the use of acetaminophen in pregnancy, no reliable research has conclusively proven that the consumption of paracetamol in any period of gestation leads to neurodevelopmental disorders in young ones," the association commented.

The court filing mentions recent announcements from the former administration in arguing the medication is reportedly hazardous.

Recently, the former president generated worry from medical authorities when he advised pregnant women to "resist strongly" not to take Tylenol when sick.

The FDA then published an announcement that medical professionals should think about restricting the use of Tylenol, while also declaring that "a proven link" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had pledged in April to conduct "comprehensive study program" that would establish the origin of autism spectrum disorder in a short period.

But specialists advised that discovering a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a form of permanent neurological difference and disability that affects how individuals experience and relate to the environment, and is diagnosed using doctors' observations.

In his court filing, Paxton - who supports Trump who is seeking the Senate - alleges the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism.

The case attempts to require the companies "destroy any marketing or advertising" that asserts Tylenol is secure for pregnant women.

This legal action parallels the complaints of a group of parents of children with autism and ADHD who took legal action against the manufacturers of Tylenol in two years ago.

Judicial authorities threw out the case, declaring research from the parents' expert witnesses was not conclusive.